TW200800944A - Benzamide compounds - Google Patents
Benzamide compoundsInfo
- Publication number
- TW200800944A TW200800944A TW095138558A TW95138558A TW200800944A TW 200800944 A TW200800944 A TW 200800944A TW 095138558 A TW095138558 A TW 095138558A TW 95138558 A TW95138558 A TW 95138558A TW 200800944 A TW200800944 A TW 200800944A
- Authority
- TW
- Taiwan
- Prior art keywords
- compounds
- benzamide compounds
- concerns
- 4alkoxy
- 4alkyl
- Prior art date
Links
- 150000003936 benzamides Chemical class 0.000 title abstract 2
- 102000003964 Histone deacetylase Human genes 0.000 abstract 2
- 108090000353 Histone deacetylase Proteins 0.000 abstract 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 1
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 1
- 125000006645 (C3-C4) cycloalkyl group Chemical group 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 230000001028 anti-proliverative effect Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000000000 cycloalkoxy group Chemical group 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 239000000651 prodrug Chemical group 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 230000002062 proliferating effect Effects 0.000 abstract 1
- 125000003226 pyrazolyl group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0521244.4A GB0521244D0 (en) | 2005-10-19 | 2005-10-19 | Benzamide compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW200800944A true TW200800944A (en) | 2008-01-01 |
| TWI385162B TWI385162B (zh) | 2013-02-11 |
Family
ID=35458263
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW095138558A TWI385162B (zh) | 2005-10-19 | 2006-10-19 | 苯甲醯胺化合物 |
Country Status (32)
| Country | Link |
|---|---|
| US (2) | US8207202B2 (zh) |
| EP (1) | EP1954690B1 (zh) |
| JP (1) | JP5340736B2 (zh) |
| KR (1) | KR101464004B1 (zh) |
| CN (1) | CN101331123B (zh) |
| AR (1) | AR057162A1 (zh) |
| AU (1) | AU2006303111B2 (zh) |
| BR (1) | BRPI0617654B8 (zh) |
| CA (1) | CA2625970C (zh) |
| CY (1) | CY1114521T1 (zh) |
| DK (1) | DK1954690T3 (zh) |
| EC (1) | ECSP088457A (zh) |
| ES (1) | ES2422859T3 (zh) |
| GB (1) | GB0521244D0 (zh) |
| HK (1) | HK1121749A1 (zh) |
| HR (1) | HRP20130683T1 (zh) |
| IL (1) | IL190429A (zh) |
| ME (1) | ME01595B (zh) |
| MY (1) | MY145569A (zh) |
| NO (1) | NO340878B1 (zh) |
| NZ (1) | NZ566944A (zh) |
| PL (1) | PL1954690T3 (zh) |
| PT (1) | PT1954690E (zh) |
| RS (1) | RS52881B (zh) |
| RU (1) | RU2448965C2 (zh) |
| SA (1) | SA06270384B1 (zh) |
| SI (1) | SI1954690T1 (zh) |
| TW (1) | TWI385162B (zh) |
| UA (1) | UA98757C2 (zh) |
| UY (1) | UY29869A1 (zh) |
| WO (1) | WO2007045844A1 (zh) |
| ZA (1) | ZA200803096B (zh) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102007028198A1 (de) | 2007-06-16 | 2008-12-24 | Schebo (R) . Biotech Ag | Neue Pharmazeutika, Verfahren zu ihrer Herstellung und ihre Verwendung in der Therapie |
| WO2009118370A1 (en) | 2008-03-27 | 2009-10-01 | Janssen Pharmaceutica Nv | Aza-bicyclohexyl substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase |
| WO2010028192A1 (en) | 2008-09-03 | 2010-03-11 | Repligen Corporation | Compositions including 6-aminohexanoic acid derivatives as hdac inhibitors |
| KR20120031170A (ko) * | 2009-06-08 | 2012-03-30 | 길리애드 사이언시즈, 인코포레이티드 | 알카노일아미노 벤즈아미드 아닐린 ｈｄａｃ 저해제 화합물 |
| US8957066B2 (en) | 2011-02-28 | 2015-02-17 | Biomarin Pharmaceutical Inc. | Histone deacetylase inhibitors |
| PT2680694T (pt) | 2011-02-28 | 2019-03-14 | Biomarin Pharm Inc | Inibidores de histona deacetilase |
| US10059723B2 (en) | 2011-02-28 | 2018-08-28 | Biomarin Pharmaceutical Inc. | Histone deacetylase inhibitors |
| EP2968233A4 (en) | 2013-03-14 | 2016-08-03 | Chdi Foundation Inc | HISTON DEACETYLASE HEMMER AND COMPOSITIONS AND METHOD FOR USE THEREOF |
| US9617259B2 (en) | 2013-03-14 | 2017-04-11 | Chdi Foundation, Inc. | Histone deacetylase inhibitors and compositions and methods of use thereof |
| US20160031863A1 (en) * | 2013-03-14 | 2016-02-04 | Chdi Foundation, Inc. | Histone deacetylase inhibitors and compositions and methods of use thereof |
| AU2014228344C1 (en) | 2013-03-15 | 2019-02-07 | Biomarin Pharmaceutical Inc. | HDAC inhibitors |
| AU2014260605B2 (en) * | 2013-04-29 | 2016-07-14 | Chong Kun Dang Pharmaceutical Corp. | Novel compounds for selective histone deacetylase inhibitors, and pharmaceutical composition comprising the same |
| CN106535891A (zh) | 2014-06-02 | 2017-03-22 | Chdi基金会股份有限公司 | 组蛋白脱乙酰酶抑制剂及其组合物和使用方法 |
| KR102236356B1 (ko) * | 2017-11-24 | 2021-04-05 | 주식회사 종근당 | 루푸스의 예방 또는 치료를 위한 조성물 |
| GB201914006D0 (en) * | 2019-09-27 | 2019-11-13 | Celleron Therapeutics Ltd | Combination Therapy |
| GB201913988D0 (en) * | 2019-09-27 | 2019-11-13 | Celleron Therapeutics Ltd | Novel treatment |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH117273A4 (zh) * | 1973-01-26 | 1976-07-15 | ||
| CH187973A4 (de) * | 1973-02-09 | 1977-03-31 | Hoechst Ag | Verfahren zum optischen Aufhellen von Textilmaterialien |
| DE2918965A1 (de) * | 1979-05-11 | 1980-11-20 | Bayer Ag | Benzofuranverbindungen sowie deren verwendung als optische aufheller |
| IT1232252B (it) * | 1989-02-22 | 1992-01-28 | Rotta Research Lab | Derivati della n fenil benzamide ad attivita' antiulcera ed antiallerica e procedimento per la loro preparazione |
| JPH05239069A (ja) | 1992-02-28 | 1993-09-17 | Canon Inc | 液晶性化合物、これを含む液晶組成物、それを有する液晶素子、それらを用いた表示方法および表示装置 |
| JP4405602B2 (ja) | 1998-04-16 | 2010-01-27 | バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト | ヒストン脱アセチル化酵素阻害剤 |
| GB9826412D0 (en) | 1998-12-03 | 1999-01-27 | Glaxo Group Ltd | Chemical compounds |
| JP4390024B2 (ja) | 1999-04-23 | 2009-12-24 | アステラス製薬株式会社 | 新規なジアゼパン誘導体又はその塩 |
| US6632815B2 (en) * | 1999-09-17 | 2003-10-14 | Millennium Pharmaceuticals, Inc. | Inhibitors of factor Xa |
| IL148698A0 (en) | 1999-09-17 | 2002-09-12 | Cor Therapeutics Inc | INHIBITORS OF FACTOR Xa |
| DK1233958T3 (da) | 1999-11-23 | 2011-10-17 | Methylgene Inc | Hæmmere af histondeacetylase |
| AU776053B2 (en) | 2000-03-31 | 2004-08-26 | Astellas Pharma Inc. | Diazepan derivatives or salts thereof |
| EP1217000A1 (en) | 2000-12-23 | 2002-06-26 | Aventis Pharma Deutschland GmbH | Inhibitors of factor Xa and factor VIIa |
| KR20040048411A (ko) | 2001-09-14 | 2004-06-09 | 메틸진, 인크. | 히스톤 데아세틸라아제의 억제제 |
| DE10204115A1 (de) * | 2002-02-01 | 2003-08-07 | Bayer Cropscience Ag | DELTA·1·-Pyrroline |
| TWI319387B (en) * | 2002-04-05 | 2010-01-11 | Astrazeneca Ab | Benzamide derivatives |
| GB0209715D0 (en) * | 2002-04-27 | 2002-06-05 | Astrazeneca Ab | Chemical compounds |
| US20040072770A1 (en) | 2002-07-03 | 2004-04-15 | Besterman Jeffrey M. | Methods for specifically inhibiting histone deacetylase-7 and 8 |
| AR043633A1 (es) | 2003-03-20 | 2005-08-03 | Schering Corp | Ligandos de receptores de canabinoides |
| EP1663953A1 (en) | 2003-09-24 | 2006-06-07 | Methylgene, Inc. | Inhibitors of histone deacetylase |
| AU2005225471B2 (en) | 2004-03-26 | 2011-05-12 | Methylgene Inc. | Inhibitors of histone deacetylase |
| AR050926A1 (es) | 2004-09-03 | 2006-12-06 | Astrazeneca Ab | Derivados de benzamida como inhibidores de la histonadesacetilasa(hdac) |
| GB0427758D0 (en) | 2004-12-18 | 2005-01-19 | Astrazeneca Ab | Novel benzamide compounds |
| GB0500828D0 (en) | 2005-01-15 | 2005-02-23 | Astrazeneca Ab | Benzamide derivatives |
| GB0501146D0 (en) | 2005-01-20 | 2005-02-23 | Astrazeneca Ab | Novel benzamide derivatives |
| GB0526351D0 (en) | 2005-12-23 | 2006-02-01 | Astrazeneca Ab | Novel benzamide derivatives |
| GB0526352D0 (en) | 2005-12-23 | 2006-02-01 | Astrazeneca Ab | Benzamide derivatives |
-
2005
- 2005-10-19 GB GBGB0521244.4A patent/GB0521244D0/en not_active Ceased
-
2006
- 2006-10-17 CA CA2625970A patent/CA2625970C/en active Active
- 2006-10-17 JP JP2008536114A patent/JP5340736B2/ja active Active
- 2006-10-17 BR BRPI0617654A patent/BRPI0617654B8/pt active IP Right Grant
- 2006-10-17 PL PL06794783T patent/PL1954690T3/pl unknown
- 2006-10-17 DK DK06794783.8T patent/DK1954690T3/da active
- 2006-10-17 WO PCT/GB2006/003838 patent/WO2007045844A1/en active Application Filing
- 2006-10-17 NZ NZ566944A patent/NZ566944A/en unknown
- 2006-10-17 KR KR1020087011411A patent/KR101464004B1/ko active IP Right Grant
- 2006-10-17 US US12/090,611 patent/US8207202B2/en active Active
- 2006-10-17 AU AU2006303111A patent/AU2006303111B2/en active Active
- 2006-10-17 ME MEP-2013-85A patent/ME01595B/me unknown
- 2006-10-17 CN CN200680047678.9A patent/CN101331123B/zh active Active
- 2006-10-17 UA UAA200805465A patent/UA98757C2/ru unknown
- 2006-10-17 SI SI200631627T patent/SI1954690T1/sl unknown
- 2006-10-17 ES ES06794783T patent/ES2422859T3/es active Active
- 2006-10-17 RS RS20130325A patent/RS52881B/en unknown
- 2006-10-17 PT PT67947838T patent/PT1954690E/pt unknown
- 2006-10-17 EP EP06794783.8A patent/EP1954690B1/en active Active
- 2006-10-17 RU RU2008119411/04A patent/RU2448965C2/ru active
- 2006-10-18 UY UY29869A patent/UY29869A1/es not_active Application Discontinuation
- 2006-10-19 TW TW095138558A patent/TWI385162B/zh active
- 2006-10-19 AR ARP060104581A patent/AR057162A1/es active IP Right Grant
- 2006-10-28 SA SA6270384A patent/SA06270384B1/ar unknown
-
2008
- 2008-03-25 IL IL190429A patent/IL190429A/en active IP Right Grant
- 2008-04-01 NO NO20081582A patent/NO340878B1/no unknown
- 2008-04-08 ZA ZA200803096A patent/ZA200803096B/xx unknown
- 2008-04-16 MY MYPI20081121A patent/MY145569A/en unknown
- 2008-05-17 EC EC2008008457A patent/ECSP088457A/es unknown
- 2008-11-27 HK HK08112997.0A patent/HK1121749A1/xx unknown
-
2012
- 2012-05-15 US US13/472,095 patent/US8735429B2/en active Active
-
2013
- 2013-07-22 HR HRP20130683TT patent/HRP20130683T1/hr unknown
- 2013-07-31 CY CY20131100650T patent/CY1114521T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200800944A (en) | Benzamide compounds | |
| TW200736232A (en) | Pyrimidine derivatives | |
| CR20200312A (es) | Nuevas piridopirimidinonas sustituidas con bencilamino y derivados como inhibidores de sos1 | |
| MX2022010520A (es) | Macrociclos peptidicos contra acinetobacter baumannii. | |
| MX2009000884A (es) | Derivados de piridizinona. | |
| MX2010009752A (es) | Compuestos de oxadiazoantraceno para el tratamiento de diabetes. | |
| TW200613298A (en) | Benzamide compounds | |
| TW200626553A (en) | Novel compounds | |
| TW200833370A (en) | Pharmaceutical composition containing low substituted hydroxypropylcellulose | |
| HK1128283A1 (en) | Aminophenyl derivatives as novel inhibitors of histone deacetylase | |
| HK1128286A1 (en) | Heterocyclylalkyl derivatives as inhibitors of histone deacetylase | |
| EA202090688A1 (ru) | Бис-амидные соединения, активирующие саркомер, и варианты их применения | |
| MX2020005841A (es) | Derivados de 1,2,4-oxadiazol como inhibidores de histona-desacetilasa 6. | |
| PH12020552186A1 (en) | Cyanotriazole compounds and uses thereof | |
| PH12020551341A1 (en) | 4-methyldihydropyrimidinone compounds and pharmaceutical use thereof | |
| TW200637823A (en) | Novel benzamide derivatives | |
| TW200637824A (en) | Benzamide derivatives | |
| MX2014003334A (es) | Derivados de tio novedosos que tienen lactamas como potentes inhibidores de hdac y sus usos como medicamentos. | |
| PH12020500120A1 (en) | Pharmaceutical compositions | |
| MX2010004405A (es) | Derivados de pirrolo [1,2-c] imidazol para utilizarse en la profilaxis o tratamiento de cancer que es refractario a terapias cancerigenas conocidas. | |
| GEP20064009B (en) | Cetylpyridinium salt of an anti-inflammatory agent and armaceutical compositions containing it | |
| TN2010000373A1 (en) | The present invention provides oxadiazoanthracene | |
| TH88497B (th) | สารประกอบเบนแซมีด |